LINEZOLID GXP linezolid 600 mg tablet blister pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

linezolid, Quantity: 600 mg

Available from:

Arrotex Pharmaceuticals Pty Ltd

INN (International Name):

Linezolid

Pharmaceutical form:

Tablet, film coated

Composition:

Excipient Ingredients: povidone; sodium starch glycollate; microcrystalline cellulose; magnesium stearate; sodium dihydrogen citrate; titanium dioxide; hypromellose; PEG-40 stearate

Administration route:

Oral

Units in package:

30, 10

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Linezolid is indicated for the treatment of suspected or proven infections due to Gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant Staphylococcus species and vancomycin resistant Enterococcus species.,Linezolid is active against Gram-positive bacteria only. Linezolid has no clinical activity against Gram-negative pathogens. Specific Gram-negative therapy is required if a concomitant Gram-negative pathogen is documented or suspected.

Product summary:

Visual Identification: Off-white, oblong, biconvex, film-coated tablet.; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2016-01-28